Insiders · Profile

Quinn William P.

President, CEO and CFO at Bolt Biotherapeutics. Filing since 9 Feb 2021. CIK 0001724190

Company
Date
Role
Action
Shares
Amount
Of holding
18 Sep 2026
President, CEO and CFO
Sold at will
9,132
$29.55K
26.5%
17 Sep 2026
President, CEO and CFO
Sold at will
6,545
$21.72K
15.9%
16 Sep 2026
President, CEO and CFO
Sold at will
1,889
$7.13K
4.4%
5 Jun 2026
President, CEO and CFO
Bought
637
$2.47K
27.5%
5 Dec 2025
President, CEO and CFO
Bought
125
$575.88
5.7%
6 Jun 2025
President, CEO and CFO
Bought
125
$686.50
6.1%
16 Dec 2024
President, CEO and CFO
Bought
2,500
$1.24K
6.4%
6 Jun 2024
President, CEO and CFO
Bought
2,500
$1.59K
6.9%
12 Dec 2023
Chief Financial Officer
Bought
7,500
$7.13K
26.1%
6 Dec 2023
Chief Financial Officer
Bought
2,500
$1.96K
9.5%
6 Jun 2023
Chief Financial Officer
Bought
1,829
$2.16K
7.5%
8 Dec 2021
Chief Financial Officer
Bought
5,000
$23.58K
33.0%
6 Dec 2021
Chief Financial Officer
Bought
35
$162.40
0.2%
4 Jun 2021
Chief Financial Officer
Bought
1,221
$20.33K
8.8%
9 Feb 2021
Chief Financial Officer
Bought
1,200
$24.00K
9.5%
15 decisions on file.